SynDevRx has developed proprietary drug conjugation chemistries that dramatically increase the activity of small molecule drugs while improving their safety profile and physical attributes.
Optimied Drug Conjugates
Conjugated MetAP2 Inhibitors
For more information or to inquire about licensing our technology, please contact us.
NB: SynDevRx is not affiliated with Children's Hospital Boston.